Part B Reforms: MedPAC Moving Forward With 'Drug Value Program' Proposal

07 Mar 2017

• By Laura Helbling

Even under most ambitious timeline, new competitive-bidding approach would not start before 2022 – and that assumes Congress has appetite for the legislation with an already full plate of health care work to do. But new ideas in Part B are worth watching.

Anti-recessionary injection (vaccination) by hundred dollar denomination close up on a black background

The Medicare Payment Advisory Commission will vote in April on a proposal to recommend enactment of private third party negotiation model to control the cost of physician administered drugs under Part B.

MedPAC discussed a proposal for a so-called Drug Value Program (DVP) at its March 2 meeting. The commission’s...